Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in

  News Archive

“Heat” From Chilli Peppers Could Help Kill Cancer Cells
Friday, September 11, 2015
Capsaicin, the compound responsible for chilis’ heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells.

Genome Mining Effort Discovers 19 New Natural Products in Four Years
Friday, September 11, 2015
Each of these products is a potential new drug. One of them has already been identified as an antibiotic.

Gencia and Takeda Partner On Mitochondrial Therapeutics
Friday, September 11, 2015
The companies announced have a partnership to develop a new class of small molecule drugs as potential treatments for hematological and inflammatory diseases.

Data Shows M&A Activity Increases 44.5% In India
Friday, September 11, 2015
Exports and domestic market valued at over $15 billion each, with India expected to take 25% of biosimilars market over the next five years.

Santhera Receives European Marketing Authorization for Raxone®
Thursday, September 10, 2015
First approved treatment for LHON and first approved treatment for a mitochondrial disease.

US FDA Grants Therapy Designation for Roche’s Investigational Medicine ACE910
Tuesday, September 08, 2015
First factor VIIIa-mimetic bispecific antibody to be investigated for the prophylactic treatment of haemophilia A.

Finding a Treatment for Parkinson's Disease Dementia
Tuesday, September 08, 2015
University of Adelaide neuroscientists are leading a world-first study into a form of dementia experienced by many Parkinson’s disease suffers, which is expected to ultimately lead to a new therapy for the condition.

Sanifit Raises €36.6M in Series C Financing Round
Tuesday, September 08, 2015
Financing will advance Sanifit’s lead drug candidate through phase IIb as a treatment for cardiovascular diseases linked to calcification and through phase II/III for calciphylaxis.

Novartis, Amgen Partner
Friday, September 04, 2015
The companies plan to co-develop and co-commercialize a BACE inhibitor program in Alzheimer's Disease (AD); Novartis' oral therapy CNP520 will be the lead molecule.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 4193

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos